A more comprehensive understanding of immunological factors in the complex tumor microenvironment would be advantageous for unravelling the mechanisms underpinning carcinogenesis in aggressive breast cancer subtypes such as HER2 + breast cancer. The gene discussed is ERBB2; the disease is breast carcinoma.